Mersana Therapeutics Inc (NASDAQ:MRSN) shares, rose in value, with the stock price down by -10.28% to the previous day’s close as strong demand from buyers drove the stock to $2.88.
Actively observing the price movement in the last trading, the stock closed the session at $3.21. Referring to stock’s 52-week performance, its high was $9.62, and the low was $0.80. On the whole, MRSN has fluctuated by -32.55% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MRSN’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of MRSN currently trading nearly -26.54% and -34.99% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 23.10, while the 7-day volatility ratio is showing 8.41% which for the 30-day chart, stands at 7.24%. Furthermore, Mersana Therapeutics Inc (MRSN)’s beta value is 1.58, and its average true range (ATR) is 0.31.
A comparison of Mersana Therapeutics Inc (MRSN) with its peers suggests the former has fared considerably weaker in the market. MRSN showed an intraday change of -10.28% in last session, and over the past year, it shrunk by -30.60%%.
Data on historical trading for Mersana Therapeutics Inc (NASDAQ:MRSN) indicates that the trading volumes over the past 3 months, they’ve averaged 2.16 million. According to company’s latest data on outstanding shares, there are 120.71 million shares outstanding.
Nearly 24.18% of Mersana Therapeutics Inc’s shares belong to company insiders and institutional investors own 71.03% of the company’s shares. The stock has risen by 24.14% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MRSN stock heading into the next quarter.
